ACM
MRK icon

Altrius Capital Management’s Merck MRK Stock Holding History

Altrius Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.03M Buy
54,671
+400
+0.7% +$46.8K 1.33% 33
2026
Q1 		$6.53M Sell
54,271
-3,798
-7% -$438K 1.3% 34
2025
Q4 		$6.11M Buy
58,069
+342
+0.6% +$32.1K 1.3% 27
2025
Q3 		$4.85M Buy
57,727
+2,064
+4% +$170K 1.11% 56
2025
Q2 		$4.41M Buy
55,663
+7,124
+15% +$566K 1.03% 56
2025
Q1 		$4.36M Buy
48,539
+3,233
+7% +$302K 1.06% 59
2024
Q4 		$4.51M Buy
45,306
+6,378
+16% +$658K 1.21% 42
2024
Q3 		$4.42M Buy
38,928
+1,827
+5% +$217K 1.11% 57
2024
Q2 		$4.59M Buy
37,101
+57
+0.2% +$7.34K 1.21% 38
2024
Q1 		$4.89M Buy
37,044
+1,915
+5% +$236K 1.23% 33
2023
Q4 		$3.83M Buy
35,129
+220
+0.6% +$22.8K 1.07% 47
2023
Q3 		$3.59M Buy
34,909
+352
+1% +$37.9K 1.07% 42
2023
Q2 		$3.99M Buy
34,557
+336
+1% +$38.1K 1.18% 32
2023
Q1 		$3.64M Sell
34,221
-256
-0.7% -$27.6K 1.11% 36
2022
Q4 		$3.83M Sell
34,477
-980
-3% -$100K 1.2% 30
2022
Q3 		$3.05M Sell
35,457
-19,039
-35% -$1.7M 1.16% 33
2022
Q2 		$4.97M Buy
+54,496
New +$4.83M 1.61% 11

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Altrius Capital Management's MRK Position: Q2 2026 in Review

Altrius Capital Management increased its Merck (MRK) stake by 0.74% in Q2 2026, buying an estimated $46.8K and bringing the position to 54,671 shares worth $7.03M. The position accounts for 1.33% of the portfolio, ranked #33.

Altrius Capital Management first reported a position in MRK in Q2 2022 and has held it in 17 quarters since. 3,834 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Altrius Capital Management held 54,671 shares of Merck worth $7.03M as of Q2 2026.
  • Altrius Capital Management bought 400 Merck shares in Q2 2026, an estimated $46.8K.
  • Merck made up 1.33% of Altrius Capital Management's portfolio in Q2 2026, its #33 holding.
  • Altrius Capital Management first reported a position in Merck in Q2 2022 and has held it in 17 quarters since.
  • 3,834 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Altrius Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.